Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial (NCT05886036) | National Cancer Institute (NCI) | 2024-01-23 |
Track Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.